secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2022-07-28T23:59:59+00:00
Accession:  0001093557-22-000142
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dexcom Q2 revenue $696.2M (+17% YoY); GAAP EPS $0.12, Non-GAAP EPS $0.17
------------------------------------------------------------------------

- Revenue $696.2M, +17% reported, +16% organic; U.S. +11%, international +39% reported (+34% organic).
- GAAP operating margin 11.1% (down 590bps); Non-GAAP operating margin 14.6% (down 250bps).
- GAAP net income $50.9M ($0.12 diluted EPS); Non-GAAP net income $69.5M ($0.17 diluted EPS).
- FY2022 guidance: revenue $2.86-2.91B (17-19% growth); Non-GAAP gross margin ~65%, op margin ~16%, Adj. EBITDA ~25%.
- Launched Dexcom ONE in UK/Spain; received CE Mark for G7 sensor algorithm; launched Spanish-language G6 app.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000109355722000142/0001093557-22-000142-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000109355722000142/dxcm-20220728.htm
  HTML page:      https://secwatch.observer/filing/0001093557-22-000142

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer